Aspen Aerogels (NYSE:ASPN - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect Aspen Aerogels to post earnings of ($0.05) per share and revenue of $82.75 million for the quarter. Aspen Aerogels has set its Q1 2025 guidance at -0.180-0.000 EPS.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, analysts expect Aspen Aerogels to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Aspen Aerogels Price Performance
Aspen Aerogels stock traded up $0.04 during mid-day trading on Tuesday, hitting $5.53. 1,535,219 shares of the company traded hands, compared to its average volume of 1,881,112. The stock has a fifty day moving average price of $6.22 and a 200-day moving average price of $10.85. The stock has a market cap of $453.63 million, a price-to-earnings ratio of 34.53 and a beta of 2.72. Aspen Aerogels has a one year low of $4.80 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on ASPN shares. Barclays reduced their target price on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Finally, TD Cowen raised shares of Aspen Aerogels to a "strong-buy" rating in a research note on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Aspen Aerogels currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.11.
Read Our Latest Analysis on ASPN
Aspen Aerogels Company Profile
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.